Business

Diabetes drug

Pharmaceutical IndustryChemical IndustryFood and Drug AdministrationMannKind Corporation
MannKind Corp. of Valencia is seeking Food and Drug Administration approval of its inhaled diabetes medication, Afrezza. Damion Edwards / MannKind Corp.
This photo is featured in these articles:
Loading